Pricing Log in Create free account

Cardiff Oncology, Inc. (CRDF) vs Champions Oncology, Inc. (CSBR)

Cardiff Oncology, Inc. and Champions Oncology, Inc. are both Biotechnology companies. Champions Oncology, Inc. is the larger, with a market value of $66.3M against $58.8M — 1.1× the size. Champions Oncology, Inc. grew revenue faster over the last twelve months: 6.65% against −6.79%. Champions Oncology, Inc. has the higher net margin (−1.87% vs −7,889.0%) and the lower return on invested capital (−626.2% vs 0.00%). Across the 17 metrics below, Champions Oncology, Inc. leads on 11 and Cardiff Oncology, Inc. on 6.

Valuation

Metric CRDF CSBR Biotechnology median
P/E n/m n/m 10.26
P/S 102.33 1.10 9.18
P/B 1.96 14.93 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 200.35 0.65
EV/Sales 37.15 1.03 8.98
Earnings yield (78.95%) (1.67%) (34.89%)
Free cash flow yield (78.76%) (9.18%) (24.52%)

Profitability

Metric CRDF CSBR Biotechnology median
Gross margin 100.00% 49.82% 65.16%
Operating margin (8,320.08%) (1.68%) 0.00%
Net margin (7,888.98%) (1.87%) 0.00%
Free cash flow margin (8,059.45%) (10.08%) 0.00%
Return on equity (94.14%) (28.38%) (50.12%)
Return on assets (70.89%) (3.56%) (45.60%)
Return on invested capital 0.00% (626.23%) 0.00%

Growth

Metric CRDF CSBR Biotechnology median
Revenue growth (TTM) (6.79%) 6.65% 6.26%
EPS growth (last fiscal year) 27.37% (124.24%) 29.88%
Revenue growth, 5-year CAGR 10.13% 7.68% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRDF CSBR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.30 1.03 4.89
Net debt to EBITDA 1.18 (20.56) 1.01

Dividend

Metric CRDF CSBR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRDF CSBR Biotechnology median
Market cap 58.76m 66.26m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack